期刊文献+

PEP-1-CAT融合蛋白预处理对在体大鼠心肌缺血再灌注损伤的保护作用 被引量:1

Protective effect of preconditioning with PEP-1-CAT fusion protein against myocardial ischemia-reperfusion injury in rats
下载PDF
导出
摘要 目的观察细胞穿透肽PEP-1介导CAT转导入在体大鼠心肌组织的能力,探究PEP-1-CAT融合蛋白对在体大鼠心肌缺血再灌注损伤的保护作用。方法以生理盐水为对照,分别从SD大鼠尾静脉注射500μgPEP-1-CAT和CAT融合蛋白,在0.5,1,2,4,8,24h时将其处死,取其心脏,免疫荧光检测CAT的转导能力,用试剂盒检测心肌CAT的酶活性。40只SPF级雄性SD大鼠,随机分为5组,假手术组,心肌缺血再灌注组,100μgPEP-1-CAT融合蛋白预处理组,300μgEP-1-CAT融合蛋白预处理组,500μgPEP-1-CAT融合蛋白预处理组。结扎冠状动脉前降支1h,再灌注2h末,检测血中的LDH和CK活性以及心肌组织内的MDA含量。结果生理盐水组以及CAT组,荧光显微镜下均未见到绿色荧光;PEP-1-CAT各组均可观察到绿色荧光,且8h时强度最大;酶活性检测显示,CAT组与生理盐水对照组差别没有统计学意义(P>0.05),而PEP-1-CAT组随着时间的延长,心肌组织中CAT的活性逐渐增加,在8h时达到峰值,为对照组的4.20倍。PEP-1-CAT各剂量组均能显著减少血清中LDH和CK活性和心肌组织的MDA含量(P<0.01)。结论PEP-1能够介导CAT以时间依赖的方式转导入在体大鼠心肌组织,转导入大鼠心肌组织内的CAT具有相应的酶活性;PEP-1-CAT融合蛋白预处理对在体大鼠心肌缺血再灌注损伤具有保护作用,为临床应用PEP-1-CAT融合蛋白防治心肌缺血再灌注损伤奠定了实验基础。 Objective To investigate the transduction efficiency of purified PEP-1-CAT fusion protein into rat heart and the protective effect of the fusion protein against myocardial ischemia-reperfusion injury. Methods PEP-1-CAT or CAT (500 μg) was injected in SD rats via the caudal vein, using normal saline as the control, and the hearts were harvested at 0.5, 1, 2, 4, 8, and 24 h after the injection. The transduction efficiency was evaluated by immunofluorescence technique, and the CAT activity was measured. Forty rats were randomized into 5 groups, namely the sham-operated group, ischemia-reperfusion group, and 3 PEP-1-CAT -treated groups (100, 300, and 500 μg). The left main coronary artery was occluded for 1 h followed by a 2-h reperfusion, and at the end of reperfusion, serum LDH and CK and MDA content in the myocardium were measured. Results No green fluorescence was observed in saline group or CAT group. Bright green fluorescence was observed in PEP-1-CAT groups at different time points, most conspicuous at 8 h. No significant difference in CAT activity was found between CAT group and saline group (P0.05); with the lapse of time, CAT activity in PEP-1-CAT group increased gradually, reaching the peak level at 8 h, which was 4.2 folds of that in the saline group. LDH ,CK and MDA were significantly lower in PEP-1-CAT- groups than in ischemia-reperfusion group (P0.01). Conclusion PEP-1 can mediate the transduction of CAT in rat heart in a time-dependent manner, and PEP-1-CAT preconditioning provides a protective effect against ischemia-reperfusion injury in rats.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第12期2429-2432,共4页 Journal of Southern Medical University
基金 湖北省高等学校优秀中青年科技创新团队(T200811) 湖北省十堰市重大科技攻关项目(2006030Z)
关键词 PEP-1肽 过氧化氢酶 转导 氧化应激 心肌 缺血再灌注损伤 PEP-1 catalase transduction oxidative stress myocardial ischemia-reperfusion injury
  • 相关文献

参考文献13

  • 1金惠铭,王建枝.病理生理学[M].6版.北京:人民卫生出版社,2003:202-209.
  • 2Morris MC, Depollier J, Mery J, et al. A peptide carrier for the delivery of biologically active proteins into mammalian cell [J]. Nat Biotechnol, 2001, 19(12): 1173-6.
  • 3Yellon DM, Baxter GF. Protecting the ischemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality[J]? Heart, 2000, 83(4): 381-7.
  • 4Trehin R, Merkle HP. Chances and pitfalls of cell penetrating peptides for cellular drug delivery[J]. Eur J Pharm Biopharm, 2004, 58(2): 209-23.
  • 5Gupta B, Levchenko TS, Torchilin VP. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides[J]. Adv Drug Deliv Rev, 2005, 57(4): 637-51.
  • 6Jarver P, Langel U. The use of cell-penetrating peptides as a tool for gene regulation [J]. Drug Discov Today, 2004, 9(9): 395-402.
  • 7Li HJ, Jae HB, Won SE, et al. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells[ J ]. Free Radio Biol Med, 2001, 31 (11): 1509-19.
  • 8丁鹏,王家宁,黄永章,杨波.利用TA克隆载体构建pET15b-SOD1重组质粒[J].郧阳医学院学报,2005,24(2):65-68. 被引量:27
  • 9丁鹏,王家宁,黄永章,骆丽娜,邵芳.PEP-1肽介导人Cu,ZnSOD转导入人脐静脉内皮细胞[J].第四军医大学学报,2006,27(9):855-859. 被引量:10
  • 10姚玲玲,王家宁,黄永章,郭凌郧.利用同尾酶技术构建pET15b-PEP-1-CAT重组质粒[J].郧阳医学院学报,2006,25(1):1-5. 被引量:9

二级参考文献52

共引文献59

同被引文献14

  • 1Wittekamp BH, Bonten MJ. Antibiotic prophylaxis in the era of multidrug-resistant bacteria [J ]. Expert Opin Investig Drugs, 2012,21(6) :767- 772.
  • 2Vila-Farres X, Giralt E, Vila J. Update of peptides with anti- bacterial activity [J]. Curt Med Chem, 2012,19 (36).-6188- 6198.
  • 3Liao Z, Wang XC, Liu HH, et al. Molecular characterization of a novel antimicrobial peptide from Mytilus coruscus [J]. Fish Shellfish Immunol, 2013, 34 (2):610-616.
  • 4Gottschalk S, Gottlieb CT, Vestergaard M, et al. Amphibian antimicrobial peptide fallaxin analogue FL9 affects virulence gene expression and DNA replication in Staphylococcus aureus [J]. J MedMicrobiol, 2015, 64(12): 1504- 1513.
  • 5Chen B, Fan DQ, Zhu KX, et al. Mechanism study on a new antimicrobial peptide Sphistin derived from the N-terminus of crab histone H2A identified in haemolymphs of Scylla para- mamosain [J]. Fish Shellfish Immunol, 2015,47 (2) : 833 - 846.
  • 6Goh HF, Philip K. Purification and characterization of bacteri- ocin produced by weissella confusa A3 of dairy origin [J].PloS one, 2015,10(10) :e0140434.
  • 7Kotarsky K, Sitnik KM, Stenstad H, et al. A novel role for constitutively expressed epithelial derived chemokines as anti- bacterial peptides in the intestinal mucosa [J]. Mucosal Immu nol, 2010,3(1) :40- 48.
  • 8Liu JY, Li F, Wang LP, et al. CTL-vs Treg lymphocyte-at- tracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma [J]. Br J Cancer, 2015, 113 (5): 747 - 755.
  • 9Zhang YE, Wang JN, Tang JM, et al. In vivo protein trans duction delivery of PEP 1 SOD1 fusion protein into myocardi um efficiently protects against ischemic insult[J]. Mol Cells 2009,27(2) :159- 166.
  • 10Bukharin OV, Valyshev AV. mechanisms of resistance of en- terococci to antimicrobial proteins and peptides [J]. Zh Mikro- biol Epidemiol Immunobiol, 2012,5 : 89 - 94.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部